James J Marino - Net Worth and Insider Trading

James J Marino Net Worth

The estimated net worth of James J Marino is at least $348,422 dollars as of 2024-11-13. James J Marino is the Director of Celldex Therapeutics Inc and owns about 12,704 shares of Celldex Therapeutics Inc (CLDX) stock worth over $343,389. James J Marino is also the Director of Traws Pharma Inc and owns about 853 shares of Traws Pharma Inc (TRAW) stock worth over $5,033. Details can be seen in James J Marino's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James J Marino has not made any transactions after 2021-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James J Marino

To

James J Marino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James J Marino owns 2 companies in total, including Traws Pharma Inc (TRAW) , and Celldex Therapeutics Inc (CLDX) .

Click here to see the complete history of James J Marino’s form 4 insider trades.

Insider Ownership Summary of James J Marino

Ticker Comapny Transaction Date Type of Owner
TRAW Traws Pharma Inc 2021-09-28 director
CLDX Celldex Therapeutics Inc 2020-06-09 director

James J Marino Latest Holdings Summary

James J Marino currently owns a total of 2 stocks. Among these stocks, James J Marino owns 12,704 shares of Celldex Therapeutics Inc (CLDX) as of June 9, 2020, with a value of $343,389 and a weighting of 98.56%. James J Marino also owns 853 shares of Traws Pharma Inc (TRAW) as of September 28, 2021, with a value of $5,033 and a weighting of 1.44%.

Latest Holdings of James J Marino

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLDX Celldex Therapeutics Inc 2020-06-09 12,704 27.03 343,389
TRAW Traws Pharma Inc 2021-09-28 853 5.90 5,033

Holding Weightings of James J Marino


James J Marino Form 4 Trading Tracker

According to the SEC Form 4 filings, James J Marino has made a total of 1 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 8,305 shares on June 9, 2020, which cost James J Marino around $24,915.

According to the SEC Form 4 filings, James J Marino has made a total of 4 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 238 shares on September 28, 2021, which cost James J Marino around $24,998.

Insider Trading History of James J Marino

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James J Marino Trading Performance

GuruFocus tracks the stock performance after each of James J Marino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Marino is 105.13%. GuruFocus also compares James J Marino's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Marino within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James J Marino's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James J Marino

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 55.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 53.39 LIMIT LIMIT LIMIT LIMIT LIMIT

James J Marino Ownership Network

Ownership Network List of James J Marino

No Data

Ownership Network Relation of James J Marino

Insider Network Chart

James J Marino Owned Company Details

What does Traws Pharma Inc do?

Who are the key executives at Traws Pharma Inc?

James J Marino is the director of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .

Traws Pharma Inc (TRAW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Traws Pharma Inc Insider Transactions

No Available Data

James J Marino Mailing Address

Above is the net worth, insider trading, and ownership report for James J Marino. You might contact James J Marino via mailing address: C/o Onconova Therapeutics, 375 Pheasant Run, Newtown Pa 18940.